Save
Bookmark
Print
Sponsor Name | |
Tumor Site | Small Cell Lung Cancer |
Disease Stage | Stage IV |
Clinical Status | |
Phase | Phase III |
Intervention / Treatment | Rovalpituzumab Teserine / Topotecan |
Research Site | Montreal, QC, Sacré-Coeur Hospital |
Investigator | Dr Kevin Jao |
Telephone Number | 514-338-2222 ext 2818 |
Study Start Date | February 23, 2017 |
Study End Date | February 12, 2020 |
Trial Status | Recruitment |